Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New web tool aims to help chronically ill choose safe birth control

NCT ID NCT07075536

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This study tests a web tool called My Health, My Choice that helps people with health conditions (like diabetes or high blood pressure) understand their birth control options. About 795 participants will either use the tool before a clinic visit or receive usual care. The goal is to see if the tool reduces the number of people who don't use any birth control and helps them choose safer methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 795 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Aug 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 49 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Patient Inclusion Criteria: * Between the ages of 18 and 49 * Assigned female sex at birth, regardless of gender identity * Presumed to be fertile (have an intact uterus/tube/ovary; premenopausal) * Have at least one index health condition, characteristic or medication usage (full list of 60+ eligible conditions, characteristics, and 50+ medications available upon request); and want to talk about birth control at an upcoming clinic visit with their clinician * Able to read in English * Access to mobile phone, computer, or tablet with internet capabilities * Not currently pregnant * Desire to talk to their clinician about starting, switching, or adding a contraceptive method for the purpose of preventing pregnancy Patient Exclusion Criteria: * Trying to get pregnant in the next 12 months * Presumed infertile for any surgical or medical reason (e.g., postmenopausal, hysterectomy, chemotherapy) There are additional clarifications regarding patient eligibility, such as a full list of eligible medical diagnoses and medicines, that can be found in the protocol. Clinician Inclusion Criteria: • Any licensed clinician who provides contraceptive care at a participating clinic, including physicians, physician assistants, certified nurse midwives, nurse practitioners. (For clinicians, there are no restrictions based upon age, gender identify or sex). Clinician Exclusion Criteria: • Physician interns (PGY-1) are not eligible

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic condition are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Chronic Disease Contraception Behavior Multiple Chronic Conditions

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    19 sites in 2 countries. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ascent Center for Reproductive Health at the University of Utah

    Salt Lake City, Utah, 84112, United States

  • Boston Medical Center's Department of Family Medicine

    Boston, Massachusetts, 02119, United States

  • Capital Health Family Medicine

    Trenton, New Jersey, 08618, United States

  • Cleveland Clinic - Complex Family Planning Clinic

    Cleveland, Ohio, 44195, United States

  • Department of Family Medicine Research Office

    Ann Arbor, Michigan, 48104, United States

  • Full Circle Health Family Medicine Residency of Idaho - Nampa Program

    Nampa, Idaho, 83687, United States

  • MaineHealth Primary Care - Family Medicine - Sanford

    Sanford, Maine, 04073, United States

  • Michigan State University Health Care Family Medicine

    East Lansing, Michigan, 48824, United States

  • Mountain Area Health Education Center (MAHEC) Family Health Center - Biltmore Site and Enka Site

    Asheville, North Carolina, 28803, United States

  • Munson Healthcare

    Traverse City, Michigan, 49684, United States

  • Pomona Valley Hospital Medical Center

    Pomona, California, 91767, United States

  • Rutgers Robert Wood Johnson Medical School - Family Medicine at Monument Square

    New Brunswick, New Jersey, 08901, United States

  • University of Arizona College of Medicine - Phoenix Department of Family, Community and Preventive Medicine - Research Division & Arizona Developing Experience with Practice-Based Research Network (PBRN) Studies

    Phoenix, Arizona, 85004, United States

  • University of Kansas Medical Center Department of Family Medicine & Community Health

    Kansas City, Kansas, 66160, United States

  • University of Puerto Rico Department of Obstetrics and Gynecology

    San Juan, 00936-5067, Puerto Rico

  • Von Voigtlander Women's Hospital Obstetrics and Gynecology Clinic University of Michigan Health Michigan Medicine

    Ann Arbor, Michigan, 48109, United States

  • WMed Health Family Medicine - Crosstown Parkway

    Kalamazoo, Michigan, 49008, United States

  • West Virginia University School of Medicine - Department of Family Medicine

    Morgantown, West Virginia, 26506-9600, United States

  • Ypsilanti Health Center University of Michigan Health Michigan Medicine

    Ypsilanti, Michigan, 48197, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.